a b s t r a c t a r t i c l e i n f o
Apolipoprotein E (ApoE) functions as a ligand in receptor-mediated endocytosis of lipoprotein particles and has been demonstrated to play a role in antigen presentation. To explore the contribution of ApoE during autoimmune central nervous system (CNS) demyelination, we examined the clinical, cellular immune function, and pathologic consequences of experimental autoimmune encephalomyelitis (EAE) induction in ApoE knockout (ApoE −/− ) mice. We observed reduced clinical severity of EAE in ApoE −/− mice in comparison to WT mice that was concomitant with an early reduction of dendritic cells (DCs) followed by a reduction of additional innate cells in the spinal cord at the peak of disease without any differences in axonal damage. While T cell priming was enhanced in ApoE −/− mice, reduced severity of EAE was also observed in ApoE −/− recipients of encephalitogenic wild type T cells. Expression of ApoE during EAE was elevated within the CNS of wild type mice, particularly by innate cells such as DCs. Overall, ApoE promotes clinical EAE, likely by mediation of inflammation localized within the CNS. © 2014 Elsevier B.V. All rights reserved.
Introduction
Antigen-specific responses by autoimmune T cells targeting the central nervous system (CNS) are critical for the initiation and propagation of experimental autoimmune encephalomyelitis (EAE), an established animal model for multiple sclerosis (MS) (Kuchroo et al., 2002; Fletcher et al., 2010) . Presentation of encephalitogenic epitopes by antigen presenting cells (APCs) within the CNS is necessary for T cellmediated immune responses that induce myelin damage in EAE (Slavin et al., 2001; Tompkins et al., 2002; Becher et al., 2006; Wilson et al., 2010) . However, the crucial interactions between APCs and T cells that promote neuro-inflammation during EAE have yet to be fully established. Of the numerous APCs that are capable of driving adaptive immune responses during EAE, dendritic cells (DCs) have been shown to perform critical APC functions during every phase of EAE (Deshpande et al., 2007; Wu and Laufer, 2007; Chastain et al., 2011; Ji et al., 2013) .
Apolipoprotein E (ApoE) is a glycoprotein that functions as a ligand in receptor-mediated endocytosis of lipoprotein particles (Kim et al., 2009a) . ApoE is expressed in both the liver and CNS as well as produced by APCs such as DCs and macrophages (van den Elzen et al., 2005; Kim et al., 2009a) . The ε4 isoform of ApoE is a major genetic risk factor for sporadic Alzheimer's disease (AD) (Kim et al., 2009a) . Polymorphisms in ApoE may also contribute to the risk of developing MS and cognitive dysfunction in patients with MS (Shi et al., 2011; Yin et al., 2012) , although this remains controversial (Lill et al., 2012; Yin et al., 2012) . Recent work has shown that ApoE regulates blood-brain barrier integrity and function (Bell et al., 2012) . Therefore, the pleiotropic functions of ApoE are highly relevant to neurologic disease.
ApoE, secreted by APCs, associates with lipids and facilitates their uptake and presentation as antigens (van den Elzen et al., 2005) . As myelin is over 70% lipid (Quarles et al., 2006) , ApoE may serve as an important intermediate during the process of antigen presentation to induce autoimmune T cell responses during diseases such as MS. In addition to differing results reported recently on the role of ApoE in EAE (Dayger et al., 2012; Wei et al., 2013) , limited data exist to substantiate the role of APC-derived ApoE in EAE. To assess the importance of ApoE in neuroinflammation, we subjected mice that had undergone targeted genetic deletion of ApoE (ApoE −/− ) to EAE. We found that ApoE −/− mice prime auto-reactive CD4 T cells more efficiently than WT mice, but exhibit less severe clinical disease. In addition, ApoE is expressed at Journal of Neuroimmunology 271 (2014) 8-17 
